MPO and lung carcinoma: Moreover, patients who express more MPO due to a single-nucleotide polymorphism in the promoter region (-463 G >A, rs#2333227) are the most susceptible to lung cancer [54], as are those with other chronic inflammatory diseases in which MPO plays a pathogenic role [55, 56].